CompletedNCT00223509
Lamotrigine added to current mood stabilizers for mixed episodes in bipolarity
About this title
Read the official source — NCT00223509Medication studyAges 13–75United States
Understand this study
Who was this study for?
Listed age limits: 13 years to 75 years.
- Listed locations
- San Antonio and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 28
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 13 Years to 75 Years
- Official registry ID
- NCT00223509
- Official title
Show the full official title
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine.
Who was this study for?
Listed age limits: 13 years to 75 years.
